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Background: MicroRNAs (miRNAs) have been shown to be present in plasma, which are remarkably stable, and
have been suggested as disease biomarkers. Toxoplasma gondii (T. gondii) is a protozoan parasite that is infective to
a wide range of animals and human beings. Previous studies have found that the parasite generated a large
number of miRNAs during proliferation and it is known that the spectrum of miRNA expression in the infected
hosts is pathogen-specific. To date, there are no reports regarding the application of microRNAs as biomarkers for
the early detection of T. gondii infection.
Methods: In this study, we investigated the expression patterns of 414 murine miRNAs and tested their expression
levels in the plasma after T. gondii infection by real-time PCR, with an ultimate purpose of identifying infection-related
miRNAs. Three miRNAs in particular, exhibiting prominently elevated expressions, were further validated in a large
number of infected mice. The Toxoplasma infection-specific miRNAs were confirmed by comparing their expression
levels with those of mice infected with Plasmodium berghei, P. yoelii, P. chabaudi, Cryptosporidium parvum, Mouse
hepatitis virus, and Staphylococcus aureus.
Results: Among the 414 miRNA candidates identified by a real-time PCR array, 71 were found to be up-regulated in the
plasma of T. gondii infected mice. Three of those miRNAs (mmu-miR-712-3p, mmu-miR-511-5p and mmu-miR-217-5p)
were prominently expressed in mice infected by both the RH and ME49 strains of T. gondii. Additionally, the elevated
expression of these miRNAs was Toxoplasma-specific.
Conclusions: The levels of the three miRNAs, mmu-miR-712-3p, mmu-miR-511-5p and mmu-miR-217-5p miRNAs, were
found specifically up-regulated in plasma of mice after T. gondii infection.
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T. gondii is an obligate intracellular parasite that causes
diverse pathological effects in humans and other warm-
blooded vertebrates [1,2]. Toxoplasmosis, caused by T. gon-
dii, is a worldwide parasitic disease that is widespread in
Asia, Africa, South America, and Europe [3-5]. The parasite
can cause severe disease in immunocompromised patients
as well as in pregnant mothers [6,7]. Toxoplasmosis may
cause serious consequences in new-born babies, such as
hearing and sight impairment and neurological symptoms* Correspondence: jiangning@jlu.edu.cn; cqj@jlu.edu.cn
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unless otherwise stated.[8]. Early treatment of pregnant women could reduce the
incidence of sequelae in infected infants [9]. Detection of
early-stage toxoplasmosis is a key measure in reducing
toxoplasmosis-related health damage.
Serological studies are currently the most common
diagnostic method for acute infections; however, they
have several disadvantages. Parasite-specific antibodies
are not normally present during the early stages of infec-
tion, particularly in immunosuppressed patients and in
pregnant patients [10,11]. Other detection methods in-
clude PCR assays that are sensitive and fast and can de-
tect parasites from different samples such as amniotic
fluid and tissues [12,13]. However, the detection of
T. gondii in amniotic fluid remains unsatisfactory becauseThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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an ideal method with high specificity and high sensitivity
for the early stage diagnosis of T. gondii infection is ur-
gently needed.
MicroRNAs (miRNAs) are 21–25 nucleotide noncoding
RNA molecules that play important roles in physiological
and pathological processes [15]. T. gondii-derived miR-
NAs have been identified in different parasite strains,
which will facilitate the dissection of the parasite biology
in different biological environments [16,17]. In addition,
the miRNA expression of the host could be affected by
the invasion of T. gondii [18]. Xiao et al. reported that
miR-132 was up-regulated in T. gondii infected mice and
was associated with changes in dopamine receptor signal-
ing [19]. They also found that miR-30c-1, miR-125b-2,
miR-23b-27b-24-1 and miR-17 ~ 92 were up-regulated in
human macrophages after T. gondii infection, which were
associated with the anti-apoptosis responses of the host
cells [20]. However, the function of both parasite- and
host-derived miRNAs in association with parasite infec-
tion still needs further study.
Recently, it has been reported that miRNAs are stable
enough to be detected in the plasma. In addition, circulat-
ing miRNAs from tissues are protected from endogenous
RNAse activity [21]. The significance of plasma miRNA
levels as biochemical markers for human cancer, such as
colorectal cancer, lung cancer, pancreatic cancer, and pros-
tate cancer, has been gradually recognised [22-25]. How-
ever, to our knowledge, there are no reports on the
characterization of circulating miRNAs in the plasma of
patients with T. gondii infection.
In this study, a real-time PCR array was applied to meas-
ure the levels miRNAs from the plasma of mice infected
with T. gondii. We focused on the analysis of three miR-
NAs, mmu-miR-712-3p, mmu-miR-511-5p and mmu-miR-
217-5p, which were detected abundantly in mice infected
with the RH (Type I) and ME49 (Type II) strains of T. gon-
dii. Quantitative analysis of these miRNAs in a large set of
plasma samples from mice showed that mmu-miR-712-3p,
mmu-miR-511-5p and mmu-miR-217-5p were potentially




RH and ME49 strains of T. gondii were routinely kept in
the laboratory by cell cultivation. Sixty female BALB/c
mice (20–25 g) aged 6 to 8 weeks were randomly divided
into 3 groups. For plasma collection from mice infected
with T. gondii, 2 groups of BALB/c mice (20 mice per
group) were peritoneally infected with 106 tachyzoites of
RH or ME49 strain per mouse. Infection was confirmed
by performing Giemsa staining of peritoneal fluid and by
PCR [26,27]. 72 hours after infection, the infected micewere exsanguinated, and the blood was mixed with heparin
for the separation of plasma. Blood samples were centri-
fuged at 1200 g/min for 10 minutes at room temperature
to remove the blood cells, followed by a second centrifuga-
tion at 12000 g/min for 10 minutes at 4°C to remove cellu-
lar components. Plasma samples were stored at −80°C until
further processing. Frozen plasma of mice infected with
Plasmodium berghei, P. yoelii, P. chabaudi, Cryptosporid-
ium parvum (C. parvum), Mouse hepatitis virus (MHV),
and Staphylococcus aureus (S. aureus) were also processed
as described above. The permission to work with laboratory
animals was obtained from the Ethical Committee of the
Institute of Zoonosis, Jilin University, China (Permission
number 2008-IZ-20).
RNA isolation
Total plasma RNA was isolated with the mirVana™ miRNA
Isolation Kit (Ambion, USA) according to the manufac-
turer’s protocol. Briefly, synthetic cel-miR-39 was added
to each sample as a spike-in control, and total RNA was
purified from 400 μl of plasma. RNA was eluted with
100 μl of RNase-free water. The concentration of total
RNA samples from plasma was quantified by a Nanodrop
2000 (Nanodrop, USA). The range of the result was from
11.9 to 73.7 ng/μl.
Real-time quantitative reverse-transcription PCR
Real-time PCR of 414 mice miRNAs was performed. Total
RNA from 3 mice infected with the RH strain of T. gondii
and from 3 healthy controls was used. The reverse-
transcription reaction was initiated with 50 ng of total RNA
and was carried out in a volume of 20 μl using the miScrip-
tII Reverse Transcription kit (Qiagen, Germany). Cel-miR-
39 was used as an internal control. MiRNA concentrations
were then confirmed by real-time PCR using the miScript
SYBR Green PCR Kit (Qiagen, Germany). Universal
primers and the miRNA-specific forward primers were pro-
vided by Qiagen. Each reaction was performed in a final
volume of 20 μl containing 2 ng of cDNA, 10 μl of 2 ×
QuantiTect SYBR Green PCR Master Mix, 2 μl of 10 ×
miScript Universal Primer and 2 μl of 10 ×miScript Primer
Assay. The ABI Prism 7900 Sequence Detection System
(Ambion, USA) was used for amplification and detection.
Differences in miRNAs were normalised to cel-miR-39, de-
termined with the ΔCt method, and reported as 2-ΔCt.
Statistical analysis
The quantitative data were analysed with the Mann–Whit-
ney U test. Receiver operating characteristic (ROC) curves
were established to examine the accuracy of using miRNAs
in early stage detection for diagnosing T. gondii infection. A
p value less than 0.05 was considered statistically signifi-
cant. All statistical calculations were performed by the SPSS
19.0 software.
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Preliminary marker selection on a small set
of plasma samples
The aim of this study was to determine whether there
are any marked miRNAs with specific expression pat-
terns in mice after a T. gondii infection. We performed
the initial test using real-time PCR arrays using RNA
isolated from T. gondii-infected mice and healthy con-
trols. The levels of miRNAs found differed profoundly in
the mice before and after infection. In total, 414 miR-
NAs could be detected by real-time PCR in all 6 samples
of the plasma. Of those 414 miRNAs, 71 were signifi-
cantly up-regulated in the plasma of T. gondii-infected
mice compared to that of healthy controls. Table 1
shows the 71 miRNAs with their respective detection
quantification intensities. Quantification analysis re-
vealed that the top 15 miRNAs differed significantly be-
tween the plasma of infected mice and that of normal
controls (Figure 1). Of these miRNAs, mmu-miR-712-
3p, mmu-miR-511-5p and mmu-miR-217-5p were de-
tected with the highest abundance (the average Ct values
were 17.43, 27.45 and 26.08, respectively). Thus, the
three miRNAs were chosen for analysis in further
studies.
Independent large-scale validation on plasma samples
To further evaluate the expression of mmu-miR-712-3p,
mmu-miR-511-5p and mmu-miR-217-5p, 60 plasma
samples collected from 20 mice infected with RH strain,
20 mice infected with ME49 strain and 20 healthy con-
trols were investigated by real-time PCR. The expression
of these miRNAs was found to be significantly up-
regulated in the plasma of RH and ME49 strain infected
mice compared to that of the healthy controls by the
Mann–Whitney U test (p < 0.001, Figure 2). However, no
significant changes of the three miRNAs in the plasma
of RH strain-infected mice compared to that of ME49
strain-infected mice were observed.
ROC curve analyses revealed that the plasma levels of
mmu-miR-712-3p, mmu-miR-511-5p and mmu-miR-
217-5p were also significantly elevated in mice infected
with the RH strain of T. gondii compared to healthy
controls, with ROC curve areas of 0.959 (95% confidence
interval, 0.844 to 0.996), 0.995 (95% CI, 0.902 to 1.000)
and 0.940 (95% CI, 0.817 to 0.990), respectively (Figure 3A,
B and C). The miRNAs were also markedly increased in
mice infected with the ME49 strain of T. gondii com-
pared to healthy controls with an AUC (area under the
ROC curve) of 0.935 (95% CI, 0.810 to 0.988), 0.995
(95% CI, 0.902 to 1.000) and 0.910 (95% CI, 0.776 to
0.977), respectively (Figure 3D, E and F). In mice in-
fected with RH strain and compared to control mice, a
cut-off value of 4.94 for mmu-miR-712-3p yields a sensi-
tivity of 85% and a specificity of 100%; at a cut-off valueof 4.21 for mmu-miR-511-5p, the optimal sensitivity
and specificity were 95% and 100%, respectively; and at
a cut-off value of 2.01 for mmu-miR-217-5p, the sensi-
tivity was 100% and the specificity was 85%. Meanwhile,
for mice infected with ME49 strain and compared to
healthy controls, at a cut-off value of 4.34 for mmu-
miR-712-3p, the sensitivity was 85% and the specificity
was 100%; at a cut-off value of 3.77 for mmu-miR-511-
5p, the optimal sensitivity and specificity were 95% and
100%; respectively; and at a cut-off value of 4.20 for
mmu-miR-217-5p, the sensitivity was 80% and the
specificity was 95%.The elevated expression of miRNAs was specific to
T. gondii infection
We further investigated if the three elevated circulating
miRNAs in plasma, mmu-miR-712-3p, mmu-miR-511-
5p and mmu-miR-217-5p, were host specific responses
to T. gondii infection. The expression levels of the three
miRNAs in mice infected with P. berghei, P. yoelii,
P. chabaudi, C. parvum, MHV, and S. aureuswere com-
pared to the expression levels of mice infected with
T. gondii. We surprisingly found that the expression of
the three miRNAs was up-regulated only in T. gondii-in-
fected mice and down-regulated in the mice infected by
the other agents (p < 0.001, Figure 4).Discussion
Accumulated evidence suggests that small molecules in
body fluids are novel markers for the clinical diagnosis of
diseases [28-30]. Measurement of plasma miRNA concen-
trations comprises a very promising field for clinical appli-
cations. Tumour-derived miRNAs were first shown to be
present in the plasma in 2008 [21]. Lawrie et al. reported
that miRNA-21 was a potentially non-invasive diagnostic
marker for B cell lymphoma, which was associated with
relapse-free survival [31]. McDonald et al. found that
miRNA concentrations were higher in the plasma than in
sera and that miRNAs were quite stable when frozen for
72 h [32]. During the last decade, circulating miRNAs as
stable blood-based biomarkers have been intensively in-
vestigated for the early detection of colorectal cancer, lung
cancer, pancreatic cancer, and prostate cancer.
To date, the correlation between plasma miRNA levels
and T. gondii infection has not been investigated. Here,
we found that the detection of circulating miRNAs in
the plasma of T. gondii-infected mice was feasible and
that 15 miRNAs were found to be significantly
up-regulated in the plasma of T. gondii-infected mice
compared to healthy mice, with fold changes >10. The
expression of the three miRNAs mmu-miR-712-3p, mmu-
miR-511-5p and mmu-miR-217-5p were further assessed
in a large number of mice infected with either RH or
Table 1 Seventy-one differentially expressed (p < 0.05) circulating miRNAs in infected and control plasma samples
MiRNAs Fold changes p-value Increased or decreased
mmu-miR-712-3p 80.62 9.22E-07 Increased
mmu-mir-511-5p 47.93 0.00133 Increased
mmu-miR-712-5p 36.60 4.99E-06 Increased
mmu-miR-217-5p 26.45 0.00073 Increased
mmu-miR-192-3p 23.69 0.00024 Increased
mmu-miR-129-1-3p 21.99 0.00016 Increased
mmu-miR-721 20.19 0.00018 Increased
mmu-miR-34a-3p 18.54 0.00065 Increased
mmu-miR-511-3p 13.76 0.00024 Increased
mmu-miR-302a-5p 13.26 0.00470 Increased
mmu-miR-122-5p 12.02 0.00291 Increased
mmu-miR-713 11.59 0.00043 Increased
mmu-miR-702-3p 11.59 0.00036 Increased
mmu-miR-144-5p 11.54 0.00285 Increased
mmu-miR-711 10.50 0.00047 Increased
mmu-miR-715 9.47 0.00049 Increased
mmu-miR-532-3p 9.08 0.00070 Increased
mmu-miR-361-5p 9.07 0.00087 Increased
mmu-miR-543-3p 8.78 0.00096 Increased
mmu-mir-194-1-3p 8.75 0.00213 Increased
mmu-miR-362-3p 8.32 0.00267 Increased
mmu-miR-532-5p 8.17 0.00090 Increased
mmu-miR-10a-5p 7.85 0.02967 Increased
mmu-miR-705 7.47 0.00212 Increased
mmu-miR-770-5p 7.31 0.00171 Increased
mmu-miR-218-2-3p 7.27 0.00234 Increased
mmu-miR-493-5p 7.05 0.02691 Increased
mmu-miR-762 7.03 0.00315 Increased
mmu-miR-714 7.01 0.00216 Increased
mmu-miR-187-5p 6.84 0.00173 Increased
mmu-miR-34a-5p 6.67 0.02440 Increased
mmu-miR-744-3p 6.55 0.00688 Increased
mmu-miR-224-3p 6.45 0.01630 Increased
mmu-miR-365-2-5p 6.20 0.00236 Increased
mmu-miR-455-5p 6.09 0.03206 Increased
mmu-miR-122-3p 5.84 0.02323 Increased
mmu-miR-145a-3p 5.82 0.01150 Increased
mmu-miR-599 5.70 0.01257 Increased
mmu-miR-132-3p 5.66 0.03740 Increased
mmu-miR-345-3p 5.61 0.00401 Increased
mmu-miR-320-3p 5.50 0.00795 Increased
mmu-miR-222-5p 5.43 0.00712 Increased
mmu-miR-338-3p 5.39 0.04550 Increased
mmu-miR-323-3p 5.26 0.00462 Increased
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Table 1 Seventy-one differentially expressed (p < 0.05) circulating miRNAs in infected and control plasma samples
(Continued)
mmu-mir-92b-5p 5.21 0.00752 Increased
mmu-miR-760-3p 5.10 0.00402 Increased
mmu-miR-130a-5p 4.94 0.00437 Increased
mmu-miR-212-3p 4.91 0.04220 Increased
mmu-miR-490-5p 4.89 0.00717 Increased
mmu-miR-7a-1-3p 4.73 0.00781 Increased
mmu-miR-363-5p 4.71 0.01730 Increased
mmu-miR-500-3p 4.68 0.04449 Increased
mmu-miR-34b-3p 4.42 0.03696 Increased
mmu-miR-188-3p 4.39 0.01057 Increased
mmu-miR-709 4.34 0.01377 Increased
mmu-miR-30d-3p 4.18 0.02385 Increased
mmu-miR-362-5p 4.09 0.01157 Increased
mmu-miR-448-3p 4.03 0.02179 Increased
mmu-miR-7a-5p 3.94 0.02428 Increased
mmu-miR-196a-5p 3.91 0.04891 Increased
mmu-miR-706 3.89 0.01287 Increased
mmu-miR-361-3p 3.78 0.01351 Increased
mmu-miR-330-5p 3.60 0.02304 Increased
mmu-miR-544-3p 3.20 0.02653 Increased
mmu-miR-135a-1-3p 3.07 0.04930 Increased
mmu-miR-710 2.95 0.04910 Increased
mmu-mir-181a-2-3p 2.82 0.04925 Increased
mmu-miR-302a-3p 0.16 0.01834 decreased
mmu-miR-495-3p 0.16 0.02215 decreased
mmu-miR-454 0.16 0.04909 decreased
mmu-miR-688 0.05 0.02774 decreased
Figure 1 The top 15 circulating miRNAs with detectable fold
changes. Total RNA extracted from plasma of T. gondii-infected
mice (n = 3) and healthy controls (n = 3) was analysed by a real-time
PCR assay. Y-axis represents the average fold change of the
3 samples.
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were consistently up-regulated in the infected mice.
The reliability of the three miRNAs as markers for
T. gondii infection was further scrutinised by ROC analysis,
an analytical method frequently applied in previous studies.
The AUC values of the tests of the three miRNAs in the in-
fected mice were between 0.910 and 0.995 with sensitivities
between 80% and 95%, and a specificity of 100%. Thus, the
three miRNAs are likely to be specific responses to T. gon-
dii infection. The miRNAs mmu-miR-712-5p and mmu-
miR-712-3p are the mature forms of mmu-miR-712, but
the locations of their coding genes are still uncertain and
their function unknown. Although both mmu-miR-712-5p
and mmu-miR-712-3p were up-regulated in the plasma
samples of T. gondii-infected mice, mmu-miR-712-3p was
more significantly up-regulated. Therefore, we chose mmu-
miR-712-3p for further investigation. In previous studies,
Son et al. reported that mmu-miR-712 derived from pre-
ribosomal RNA induced endothelial inflammation and
Figure 2 Validation of mmu-miR-712-3p, mmu-miR-511-5p and mmu-miR-217-5p in plasma samples (n = 60). Scatter plots of plasma
levels of mmu-miR-712-3p (A), mmu-miR-511-5p (B), and mmu-miR-217-5p (C) in mice infected with RH and ME49 strains of T. gondii (n = 20
each) and in healthy subjects (n = 20). Dark lines represent the mean values where appropriate. Expression levels of the miRNAs (log2 scale on the
y-axis) were normalised to cel-miR-39.
Figure 3 ROC curve analysis of the expression of plasma levels of mmu-miR-712-3p, mmu-miR-511-5p and mmu-miR-217-5p. A, B, and C
represent ROC curves of the three miRNAs in mice infected with RH strain of T. gondii compared to healthy controls. D, E, and F represent ROC curves
of the three miRNAs in mice infected with ME49 strain of T. gondii compared to healthy controls. (A) Plasma mmu-miR-712-3p yielded a ROC curve
value of 0.959 (95% Cl, 0.844 to 0.996), sensitivity of 85%, and specificity of 100%. (B) Plasma mmu-miR-511-5p yielded a ROC curve value of 0.995 (95%
Cl, 0.902 to 1.000), sensitivity of 95%, and specificity of 100%. (C) Plasma mmu-miR-217-5p yielded a ROC curve value of 0.940 (95% Cl, 0.817 to 0.990),
sensitivity of 100%, and specificity of 85%. (D) Plasma mmu-miR-712-3p yielded a ROC curve value of 0.935 (95% Cl, 0.810 to 0.988), sensitivity of 85%,
and specificity of 100%. (E) Plasma mmu-miR-511-5p yielded a ROC curve value of 0.995 (95% Cl, 0.902 to 1.000), sensitivity of 95%, and specificity of
100%. (F) Plasma mmu-miR-217-5p yielded a ROC curve value of 0.910 (95% Cl, 0.776 to 0.977), sensitivity of 80%, and specificity of 95%.
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Figure 4 Relative levels of plasma mmu-miR-712-3p (A), mmu-miR-511-5p (B), and mmu-miR-217-5p (C) in mice infected with T. gondii
RH and ME49 strains, P. berghei, P. yoelii, P. chabaudi, C. parvum, MHV, and S. aureus compared to healthy controls. The levels of the
three miRNAs were specifically up-regulated in the plasma of mice infected with T. gondii compared to that in the plasma of mice infected by
other organisms (**p < 0.001).
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vascular smooth muscle cell calcification by disrupting
Ca2+ efflux proteins, which is not related to T. gondii infec-
tion [34]. Mmu-miR-511-5p was found significantly up-
regulated in the brain tissues of Angiostrongylus cantonensis
(A. cantonensis) infected mice. This miRNA might play im-
portant role in the regulation of eosinophilic meningitis
caused by A. cantonensis infection [35]. MiR-511 has been
reported to positively regulate TLR4, as well as control
macrophage production and activation [36]. Macrophages
are important cells involved in the immune response to
T. gondii infection and have been shown to inhibit parasite
invasion and replication [37]. The elevated expression of
mmu-miR-511-5p was likely a sign of host immune
responses to T. gondii infection. However, further expe-
riments are required to reveal the function of mmu-miR-
511-5p during T. gondii infections. Another over-expressed
miRNA from the plasma of mice with T. gondii infection is
mmu-miR-217-5p, which is known to be encoded by a gene
located on chromosome 11. Previous studies indicated that
miR-217 may act as a tumour suppressor, as suggested
from a study on renal cell carcinoma and pancreatic ductal
adenocarcinoma [38,39]. Up-regulation of miR-217 could
decrease the expression of KRAS protein, thereby inhibiting
tumour cell growth [39]. However, the function of mmu-
miR-217-5p in mice infected with T. gondii remains to be
investigated.
To further determine that the up-regulation of mmu-
miR-712-3p, mmu-miR-511-5p and mmu-miR-217-5p
was specific response to T. gondii infection, we com-
pared the expression of these three miRNAs in mice
infected with T. gondii to mice infected with P. berghei,
P. yoelii, P. chabaudi, C. parvum, MHV, or S. aureus.
The results showed that these three miRNAs were sig-
nificantly up-regulated in mice infected with T. gondiibut down-regulated in mice infected with other patho-
gens. The three murine Plasmodium species, C. par-
vum and T. gondii are all members of the phylum
Apicomplexa, and they all cause severe infections in
mice; however, the miRNA expression responses in the
hosts were quite different. Furthermore, the expression
of the three miRNAs was also found to be down-
regulated in mice infected with MHV and S. aureus.
Thus, the data collectively suggest that the elevated re-
sponses of mmu-miR-712-3p, mmu-miR-511-5p and
mmu-miR-217-5p in T. gondii infected mice were
parasite-specific.
Conclusion
We report the evidence that three miRNAs, including
mmu-miR-712-3p, mmu-miR-511-5p and mmu-miR-
217-5p, are significantly up-regulated in the plasma of
mice after T. gondii infection, which may lead to the dis-
covery of novel biomarkers for T. gondii infection.
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